Latebreakers: Combo diabetes drug gets FDA nod

Article

The FDA has approved the combination of sitagliptin (Januvia, Merck) and metformin for the treatment of Type 2 diabetes.

Recent Videos
© 2024 MJH Life Sciences

All rights reserved.